| Archive | |
| |
| 27 February 2006, Volume 94, Number 4 | |
| |
 | |
| Reviews | back to top |
| |
Mutation of the PIK3CA oncogene in human cancers B Karakas, K E Bachman & B H Park | |
| Abstract | Full Article | PDF |
455 |
Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen? J Cuzick, P Sasieni & A Howell | |
| Abstract | Full Article | PDF |
460 |
Targeting insulin-like growth factor pathways D Yee | |
| Abstract | Full Article | PDF |
465 |
| |
| Clinical Studies | back to top |
| |
High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening D M Greenfield, J Wright, J E Brown, B W Hancock, H A Davies, L O'toole, C Eiser, R E Coleman & R J Ross | |
| Abstract | Full Article | PDF |
469 |
Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients L Moureau-Zabotto, S Ricci, J P Lefranc, F Coulet, C Genestie, M Antoine, S Uzan, J P Lotz, E Touboul & R Lacave | |
| Abstract | Full Article | PDF |
473 |
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study A Demols, M Peeters, M Polus, R Marechal, F Gay, E Monsaert, A Hendlisz & J L Van Laethem | |
| Abstract | Full Article | PDF |
481 |
Malignant spinal cord compression: a retrospective audit of clinical practice at a UK regional cancer centre A McLinton & C Hutchison | |
| Abstract | Full Article | PDF |
486 |
Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial S Dixon, S J Walters, L Turner & B W Hancock | |
| Abstract | Full Article | PDF |
492 |
The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk J Melia, D Dearnaley, S Moss, L Johns, P Coulson, C Moynihan, J Sweetman, M C Parkinson, R Eeles & M Watson & collaborating consultants | |
| Abstract | Full Article | PDF |
499 |
Feasibility of familial PSA screening: psychosocial issues and screening adherence J Sweetman, M Watson, A Norman, Z Bunstead, P Hopwood, J Melia, S Moss, R Eeles, D Dearnaley & C Moynihan | |
| Abstract | Full Article | PDF |
507 |
| |
| Translational Therapeutics | back to top |
| |
Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice C K Huynh, A M H Brodie & V C O Njar | |
| Abstract | Full Article | PDF |
513 |
Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer G Fürstenberger, R von Moos, R Lucas, B Thürlimann, H-J Senn, J Hamacher & E-M Boneberg | |
| Abstract | Full Article | PDF | Supplementary Information |
524 |
| |
| Molecular Diagnostics | back to top |
| |
FADD phosphorylation is critical for cell cycle regulation in breast cancer cells S Matsuyoshi, K Shimada, M Nakamura, E Ishida & N Konishi | |
| Abstract | Full Article | PDF |
532 |
Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status F Fritzsche, T Gansukh, C A Borgoño, M Burkhardt, S Pahl, E Mayordomo, K-J Winzer, W Weichert, C Denkert, K Jung, C Stephan, M Dietel, E P Diamandis, E Dahl & G Kristiansen | |
| Abstract | Full Article | PDF |
540 |
Prevalence of serologic reactivity against four strains of mouse mammary tumour virus among US women with breast cancer J J Goedert, C S Rabkin & S R Ross | |
| Abstract | Full Article | PDF |
548 |
Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival K Ino, K Shibata, H Kajiyama, E Yamamoto, T Nagasaka, A Nawa, S Nomura & F Kikkawa | |
| Abstract | Full Article | PDF |
552 |
Promoter methylation of P16, RAR  , E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencingR J Shaw, T Liloglou, S N Rogers, J S Brown, E D Vaughan, D Lowe, J K Field & J M Risk | |
| Abstract | Full Article | PDF |
561 |
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma M J Wallard, C J Pennington, A Veerakumarasivam, G Burtt, I G Mills, A Warren, H Y Leung, G Murphy, D R Edwards, D E Neal & J D Kelly | |
| Abstract | Full Article | PDF |
569 |
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted S Langbein | |
| Abstract | Full Article | PDF |
578 |
| |
| Genetics and Genomics | back to top |
| |
Editing of hnRNP K protein mRNA in colorectal adenocarcinoma and surrounding mucosa K Klimek-Tomczak, M Mikula, A Dzwonek, A Paziewska, J Karczmarski, E Hennig, J M Bujnicki, P Br  goszewski, O Denisenko, K Bomsztyk & J Ostrowski | |
| Abstract | Full Article | PDF |
586 |
DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer K Kawakami, A Ruszkiewicz, G Bennett, J Moore, F Grieu, G Watanabe & B Iacopetta | |
| Abstract | Full Article | PDF |
593 |
Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection Y Zhang, J H Ohyashiki, T Takaku, N Shimizu & K Ohyashiki | |
| Abstract | Full Article | PDF |
599 |
| In this issue | |
| ||
 | Reviews | |
| Clinical Studies | |
| Translational Therapeutics | |
| Molecular Diagnostics | |
| Genetics and Genomics | |
| ||
| ||
| ||
 | Preceding issue | |
 | Next issue | |
| ||
| ||
| ||
|
| ||
| ||
 | ||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2006 Cancer Research UK | ||
| |||
| Privacy Policy | |||